4//SEC Filing
Lucas Svetlana 4
Accession 0000950170-25-062942
CIK 0001339970other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:22 PM ET
Size
5.3 KB
Accession
0000950170-25-062942
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
Lucas Svetlana
Director
Transactions
- Award
Stock Option (right to buy)
2025-05-01+50,000→ 50,000 totalExercise: $3.34Exp: 2035-05-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001781292
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:22 PM ET
- Size
- 5.3 KB